Anna Kron

6PUBLICATIONS

55CO-AUTHORS

Predictive and prognostic markersMedical bacteriologyMolecular targetsCardiology (incl. cardiovascular diseases)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 10, 2026

Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses.

|May 28, 2026

Implementation of patient-reported outcomes in personalized lung cancer care: a qualitative study from the perspective of patients and health care providers.

|Dec 19, 2025

Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.

Felix John, Lea Ruge, Malte Verheyen

|Jan 21, 2023

Health economic analysis of patients treated with isavuconazole in a German comprehensive cancer centre.

Julia Jeck, Sebastian M Wingen-Heimann, Florian Jakobs

|Jan 18, 2023

An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations.

Christos Chouaid, Lise Bosquet, Nicolas Girard

|Aug 18, 2021

A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic "first wave" in a German tertiary care hospital.

Julia Jeck, Florian Jakobs, Anna Kron

Pageof 1

Frequent Collaborators

Florian Kron

Anna Rasokat

Matthias Scheffler

Julia Jeck

Malte Verheyen

Lea Ruge

Richard Riedel

Heather Scharpenseel

Felix John

Jürgen Wolf

Frequent Collaborators

Florian Kron

Anna Rasokat

Matthias Scheffler

Julia Jeck